Point72 Middle East FZE’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,441	Closed	-$49.9K	–	1516
2023 Q1	$49.9K	Buy	+3,441	New	+$49.9K	﹤0.01%	733